The British Journal of Radiology, Vol 71, Issue 848 892-894, Copyright © 1998 by British Institute of Radiology

ARTICLES

Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol

S Delanian
Service d'Oncologie-Radiotherapie, Hopital Saint-Louis, Paris, France.

Radiation-induced fibrosis (RIF) is a terminal sequela to irradiation that does not regress spontaneously. A preliminary study of a combination of pentoxifylline (PTX) and tocopherol (vit-E) has shown clinical activity with 50% superficial RIF regression at 6 months in half of the patients studied. The present report is of a 67-year-old woman presenting with bulky cervicothoracic RIF who, 10 years previously, had received radiochemotherapy for a small cell thyroid carcinoma to a dose of 50 Gy, with severe acute side-effects. She had palpable cervicosternal fibrosis measuring 10 x 8 cm, with local inflammatory signs and functional consequences (cough, restricted cervical movement, dyspnoea and bronchitis) with a SOMA scale for grading the long-term side effects of radiation therapy of 19/14. CT showed deep RIF extending from the vocal cords to the carina, with laryngotracheal compression but without cancer recurrence. PTX (800 mg d-1) and vit-E (1000 U d-1), orally administered daily for 18 months, were well tolerated. The patient exhibited clinical regression and functional improvement. The linear dimensions and SOMA scale were, respectively, 8 x 6 cm and 11 at 6 months; 4 x 4 cm and 7 at 12 months; and complete response with no measurable RIF and 1 at 18 months. This is the first time that the combination of PTX and vit-E has had a significant antifibrotic effect by completely reversing deep RIF as shown by CT scan normalization.

This article has been cited by other articles:

				S. Delanian, R. Porcher, J. Rudant, and J.-L. Lefaix Kinetics of Response to Long-Term Treatment Combining Pentoxifylline and Tocopherol in Patients With Superficial Radiation-Induced Fibrosis J. Clin. Oncol., December 1, 2005; 23(34): 8570 - 8579. [Abstract] [Full Text] [PDF]

				T. B Chiao and A. J Lee Role of Pentoxifylline and Vitamin E in Attenuation of Radiation-Induced Fibrosis Ann. Pharmacother., March 1, 2005; 39(3): 516 - 522. [Abstract] [Full Text] [PDF]

				A. K. Pathak, M. Bhutani, R. Guleria, S. Bal, A. Mohan, B. K. Mohanti, A. Sharma, R. Pathak, N. K. Bhardwaj, K. N. Prasad, et al. Chemotherapy Alone vs. Chemotherapy Plus High Dose Multiple Antioxidants in Patients with Advanced Non Small Cell Lung Cancer J. Am. Coll. Nutr., February 1, 2005; 24(1): 16 - 21. [Abstract] [Full Text] [PDF]

				A. K. Pathak, N. Singh, N. Khanna, V. G. Reddy, K. N. Prasad, and V. Kochupillai Potentiation of the Effect of Paclitaxel and Carboplatin by Antioxidant Mixture on Human Lung Cancer H520 Cells J. Am. Coll. Nutr., October 1, 2002; 21(5): 416 - 421. [Abstract] [Full Text] [PDF]

				B. Kumar, M. N. Jha, W. C. Cole, J. S. Bedford, and K. N. Prasad D-Alpha-Tocopheryl Succinate (Vitamin E) Enhances Radiation-Induced Chromosomal Damage Levels in Human Cancer Cells, but Reduces it in Normal Cells J. Am. Coll. Nutr., August 1, 2002; 21(4): 339 - 343. [Abstract] [Full Text] [PDF]

				F. Strutz, M. Heeg, T. Kochsiek, G. Siemers, M. Zeisberg, and G. A. Muller Effects of pentoxifylline, pentifylline and {gamma}-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1535 - 1546. [Abstract] [Full Text] [PDF]

				S. Delanian, S. Balla-Mekias, and J.-L. Lefaix Striking Regression of Chronic Radiotherapy Damage in a Clinical Trial of Combined Pentoxifylline and Tocopherol J. Clin. Oncol., October 1, 1999; 17(10): 3283 - 3290. [Abstract] [Full Text] [PDF]